Eledon Pharmaceuticals, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Eledon Pharmaceuticals, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $91.00K.
- Eledon Pharmaceuticals, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-03-31 was $115.00K.
- Eledon Pharmaceuticals, Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-12-31 was $0.00.
- Eledon Pharmaceuticals, Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-09-30 was $1.00K.
- Eledon Pharmaceuticals, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $230.00K, a 6.98% increase from fiscal 2024.
- Eledon Pharmaceuticals, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $215.00K.
- Eledon Pharmaceuticals, Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $1.00K.
- Eledon Pharmaceuticals, Inc. stock issued during period, value, stock options exercised for fiscal 2018 was $71.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $91.00K 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $230.00K 10-K · filed 2026-03-19 | |
| 2025-03-31 | $115.00K 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $215.00K 10-K · filed 2026-03-19 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $1.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $1.00K 10-Q · filed 2022-11-14 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | $71.00K 10-K · filed 2020-03-17 |
| 2018-09-30 | $71.00K 10-Q · filed 2019-11-13 | |
| 2016-12-31 | $37.00K 10-K · filed 2017-03-03 | |
| 2015-12-31 | $464.00K 10-K · filed 2017-03-03 | |
| 2014-12-31 | $16.00K 10-K · filed 2017-03-03 | |
| 2013-12-31 | $215.00K 10-K · filed 2016-03-10 | |
| 2012-12-31 | $4.00K 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |